Actinium Pharmaceuticals, Inc. (ATNM) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Actinium Pharmaceuticals, Inc. (ATNM) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

ATNM Cash Flow Statement

Actinium Pharmaceuticals, Inc. (ATNM) cash flow statement — 20-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-5.18M	-5.87M	-5.29M	-6.33M	-5.39M	-7.57M	-5.75M	-11.97M	-7.97M	-7.37M	-7.49M	-11.13M	-13.64M	-15.08M	-7.78M	-5.71M	27.92M	-5.78M	-5.05M	-5.59M
Operating CF Margin %	-14.8%	-	-	-7027.78%	-	-	-	-	-	-	-9246.91%	-	-	-	-	-12700%	62040%	-615%	-21965.22%	-2398.28%
Operating CF Growth %	3.95%	22.5%	8.03%	47.18%	32.36%	-2.71%	23.22%	-7.64%	41.57%	51.09%	3.7%	-94.66%	-148.87%	-160.8%	-53.96%	-2.27%	709.03%	-2.46%	19.27%	-11.89%
Net Income	27.9M	-5.52M	-5.94M	-5.13M	-6.88M	-15.94M	-6.65M	-11.57M	-11.35M	-8.67M	-9.32M	-13.28M	-15.18M	-11.04M	-10.65M	-9.47M	-7.77M	-5.13M	-8.01M	-6.42M
Depreciation & Amortization	241K	220K	206K	206K	204K	205K	204K	202K	189K	216K	199K	200K	209K	182K	161K	221K	180K	137K	137K	133K
Stock-Based Compensation	118K	0	10K	109K	197K	8.87M	1.2M	1.34M	1.37M	1.38M	927K	921K	1M	993K	979K	970K	425K	421K	448K	411K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	-1.52M	-1.81M	-142K	0	-38.17M	0	0	0	-1.69M	0
Other Non-Cash Items	1.21M	11K	0	0	0	0	0	0	0	0	1.52M	1.81M	142K	0	38.17M	0	0	0	1.69M	0
Working Capital Changes	-34.65M	-579K	435K	-1.51M	1.08M	-715K	-506K	-1.95M	1.82M	-298K	708K	1.03M	328K	-5.21M	1.73M	2.57M	35.08M	-1.21M	2.37M	291K
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	1.88M	-661K	997K	-1.49M	1.19M	-1.05M	371K	-1.98M	1.66M	-440K	-196K	-488K	1.28M	0	4.36M	2.1M	507K	-275K	1.2M	347K
Cash from Investing	-478K	-2K	-104K	0	0	0	0	0	0	-11K	0	-30K	-47K	-76K	-16K	-73K	-270K	-7K	0	-68K
Capital Expenditures	-478K	-2K	-104K	0	0	0	0	0	0	-11K	0	-30K	-47K	-76K	-16K	-73K	-270K	-7K	0	-68K
CapEx % of Revenue	1.37%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	162.22%	600%	0.74%	-	29.18%
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	-2K	-3K	-3K	-209K	-3K	-2K	-3K	4.6M	9.95M	14.77M	1.19M	2.86M	10.05M	770K	4.89M	1.57M	16.66M	-22K	801K	5.78M
Debt Issued (Net)	-2K	-3K	-3K	-2K	-3K	-2K	-2K	-2K	-3K	-2K	-1K	-1K	-1K	-1K	-1K	-3K	-23K	-22K	-22K	-21K
Equity Issued (Net)	0	0	0	-207K	0	0	-1K	4.6M	9.96M	14.7M	1.19M	2.86M	9.79M	770K	4.89M	1.58M	16.69M	0	823K	5.8M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	-207K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	0	0	0	75K	0	0	261K	1K	0	0	0	0	0	0
Net Change in Cash	-5.66M	-5.87M	-5.39M	-6.54M	-5.39M	-7.58M	-5.75M	-7.38M	1.98M	7.38M	-6.3M	-8.29M	-3.64M	-14.38M	-2.9M	-4.51M	44.31M	-5.81M	-4.25M	120K
Free Cash Flow	-5.66M	-5.87M	-5.39M	-6.33M	-5.39M	-7.57M	-5.75M	-11.97M	-7.97M	-7.38M	-7.49M	-11.15M	-13.69M	-15.15M	-7.79M	-5.79M	27.65M	-5.79M	-5.05M	-5.66M
FCF Margin %	-16.16%	-	-	-7027.78%	-	-	-	-	-	-	-9246.91%	-	-	-	-	-12862.22%	61440%	-615.74%	-21965.22%	-2427.47%
FCF Growth %	-4.91%	22.47%	6.22%	47.18%	32.36%	-2.56%	23.22%	-7.35%	41.77%	51.26%	3.9%	-92.73%	-149.52%	-161.8%	-54.28%	-2.33%	695.22%	-2.52%	22.31%	-13.07%
FCF per Share	-0.18	-0.19	-0.17	-0.20	-0.17	-0.24	-0.18	-0.39	-0.26	-0.26	-0.27	-0.41	-0.52	-0.59	-0.30	-0.23	1.17	-0.26	-0.23	-0.26
FCF Conversion (FCF/Net Income)	-0.19x	1.06x	0.89x	1.23x	0.78x	0.48x	0.86x	1.04x	0.70x	0.85x	0.80x	0.84x	0.90x	1.37x	0.73x	0.60x	-3.59x	1.13x	0.63x	0.87x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0